Category: Company News

DiaSorin to Acquire Luminex for $1.8B

Through the acquisition, DiaSorin will gain access to Luminex’s molecular diagnostics multiplexing technology and a portfolio that will strengthen its existing offering while expanding its presence in the United States.

Read More
Loading